|
Advertisement | |||||||||||||||||||||||||
JBC, Vol. 250, Issue 16, 6222-6227, Aug, 1975
D. M. Bleile, M. Foster, J. W. Brady and J. H. Harrison
The inactivation of cytoplasmic malate dehydrogenase (L-malate: NAD+
oxidoreductase, EC 1.1.1.37) from porcine heart and the specific
modification of arginyl residues have been found to occur when the enzyme
is inhibited with the reagent butanedione in sodium borate buffer. The
inactivation of the enzyme was found to follow pseudo-first order kinetics.
This loss of enzymatic activity was concomitant with the modification of 4
arginyl residues per molecule of enzyme. All 4 residues could be made
inaccessible to modification when a malate
dehydrogenase-NADH-hydroxymalonate ternary complex was formed. Only 2 of
the residues were protected by NADH alone and appear to be essential.
Studies of the butanedione inactivation in sodium phosphate buffer and of
reactivation of enzymatic activity, upon the removal of excess butanedione
and borate, support the role of borate ion stabilization in the
inactivation mechanism previously reported by Riordan (Riordan, J.F. (1970)
Fed. Proc. 29, Abstr. 462; Riordan, J.F. (1973) Biochemistry 12,
3915-3923). Protection from inactivation was also provided by the
competitive inhibitor AMP, while nicotinamide exhibited no effect. Such
results suggest that the AMP moiety of the NADH molecule is of major
importance in the ability of NADH to protect the enzyme. When fluorescence
titrations were used to monitor the ability of cytoplasmic malate
dehydrogenase to form a binary complex with NADH and to form a ternary
complex with NADH and hydroxymalonate, only the formation of ternary
complex seemed to be effected by arginine modification.
|
| ||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||